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Clonidine-induced cardiovascular effects after stereotaxic 
application in the hypothalamus of rats
Clonidine, a closely related analogue of the sympathomimetic imidazolines reduces 
heart rate and lowers blood pressure in animals as well as in patients with hypertension 
(Hoefke & Kobinger, 1966; Michel, Zimmerman & others, 1966). There is evidence 
that clonidine acts in the central nervous system (Sherman, Greca & others, 1968; 
Shaw, Hunyor & Komer, 1971) by activation of noradrenaline receptors (Schmitt & 
Schmitt, 1969,1970; Kobinger & Walland, 1971).
Although the findings indicate a central site of action in bulbar or diencephalic 
structures (Schmitt & Schmitt, 1969; Shaw & others, 1971), clonidine has not been 
studied after intracerebral application.
We have injected clonidine via stereotaxically implanted cannulas directly into 
various areas of the hypothalamus in anaesthesized rats while blood pressure and 
heart rate were recorded simultaneously on a Grass polygraph. Most of the injec- 
tions were made 2-5-3-5 mm anterior and 2-4—2-8 mm below the interaural line and 
0-5-0-7 mm lateral acording to the atlas of König & Klippel (1963). Details of the 
experimental procedure will be published elsewhere.
Table 1. Mean effects and s.e. of 1 /jlI amoimts o f solutions o f clonidine injected directly 
into the hypothalamus of rats on systolic blood pressure and heart rate.
Dose of B.p. just before Blood pressure fall (mg Hg) at various times after injection
clonidine injection  
(no. of exp.) (mm Hg) 1 min 5 min 15 min 30 min
1 ng (12) 135 — 0-8 ±  1-6 — 0-4 ±  2-7
3 /xg (11) 138 - 4 - 4  ±1-7* - 8 - 8  ±3-0* — 8-9 ±  4-1*
10 iig (16) 142 -5 -6  ±  0-6** -19-4  ±  2-4** -33-3  ±  4-5** —38-6 ±  6-2**
20 ng (6) 140 —2-6 ±  0-6* —21-5 ±  2-9** -34-2  ±  5-6** —40-4 ±  7-9**
Heart rate Reduction of the heart rate (beats/min)
Dose just before
(no. of exp.) injection 1 min 5 min 15 min 30 min
1 fig (12) 416 -12-5  ±  6-3 -15-0  ±  8-4
3 fig (11) 406 —19-5 ±  6-5* -25-9  ±  8-4* -22-7  ±  9-3*
10 fig (15) 416 -23-7  ±  3-0** -69-3 ±  9-3** -75 -0  ±  12-6** —72-4 ±  14-3**
20 /ig (6) 423 -12-5 ±  5-6* -56-8  ±  10-4** —103-3±12-9** —109-6 ±  6-4
* =  P  <  0-02 ** =  ƒ>< 0 001
From the results in Table 1, it is evident that a dose of 10 /xg clonidine intrahypothal- 
amically induces a strong reduction in heart rate and a lowering of the blood pressure. 
The effects of 3 /xg are clear in most rats while 1 (ig still induces a reduction in heart 
rate in most experiments, but the effect on blood pressure is negligible. At 10 jug 
the heart rate was reduced for about 1 h while blood pressure was lowered for about 
2 h. These changes were reversible.
The strongest effects of clonidine were found more lateral than medial in the far 
posterior hypothalamus at the level of fasciculus mamillotegmentalis and the decus- 
satio supramamillaris (Fig. 1).
Noradrenergic nerve terminals have been found in those sites in the hypothalmus 
where clonidine exerts its strongest cardiovascular effects (Dahlström & Fuxe, 1965)
l e t t e r s  t o  t h e  e d it o r , J. Pharm. Pharmac., 1972, 24, 411 411
F ig . 1. Saggital section through the hypothalamus of a rat with indications of the sites of injection. 
At the sites 2-13 clonidine causes both a reduction in heart rate and a fall in blood pressure. At 
1 only a blood pressure fall was observed while at 13 and 14 no effect could be obtained or cardio- 
vascular changes occurred after a latency of more than 30 min.
in agreement with an action of clonidine on adrenergic structures in the posterior 
hypothalmus.
Recent studies indicate that the antihypertensive drug methyldopa induces hypo- 
tensive effects by means of an action on the central nervous system of its metabolite 
a-methylnoradrenaline (Henning & Rubenson, 1971). Methyldopa and also the 
monoamine oxidase inhibitor pargyline may exert its hypetensive effects via nor­
adrenaline receptors in the hypothalamus.
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